In preclinical models, BPC-157 has been observed to promote the migration and proliferation of fibroblasts the primary cellular architects of connective tissue
On day 14, the primary cells were digested with trypsin and transferred to a serum-free medium
Weve seen what that looks like with compounded GLP-1s and the harm that has come with it the hospitalizations, contaminated products, and in some cases, death, PCAC cannot allow peptides to follow that same path. I don't understand how MAHA can scream about "gold standard" clinical trials for vaccines, but push for the approval of synthetic peptides without proper clinical trials
Now, RFK wants to reverse course and create a legal pathway for compounding pharmacies to dispense some peptides that have not passed through the series of studies required for FDA approval
Because both peptides mimic naturally occurring processes in the body, systemic side effects are rare